Biocon

Biocon

BIOCON

 ₹ 324.50
 ₹ 9.00
2.85%

Biocon  
Market Sentiment

TimelineReturnsVolume
Daily2.85%1,03,67,039
Weekly6.10%3,12,41,385
Monthly12.05%23,97,96,113

Biocon  
Performance

TimelineDailyWeeklyMonthly
BIOCON2.85%6.10%12.05%
Index-3.57%-1.42%-1.14%
Peer Avg.-0.14%0.72%2.16%
*Avg of index constituents

Biocon  
Fundamentals

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
BIOCON264.244.9515.586.785.840.20
Index35.445.9816.8116.9918.411.19
Peer Avg.39.554.7512.3513.5917.020.87
*Avg of index constituents

Biocon  
Key Metrics

MetricsSales GrowthProfit GrowthROEROCE
FY '21-220.13%-31.79%6.785.84
FY '20-213.12%-16.76%8.427.98
FY '19-20-5.13%-10.34%10.1710.99

Biocon  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 60.64%
FII : 15.62%
DII : 8.36%
Public : 15.39%
Others : 0%

Biocon  
Profit & Loss

MetricsSalesExpenditureEBITDAPAT
FY '21-224,961.104,183.651,215.60532.30
FY '20-214,585.753,779.101,185603.05
FY '19-204,242.353,466.451,131.95670.35
All values are in crores

Biocon  
Peer Comparison

MetricsSalesExpenditureEBITDAPAT
BIOCON4,961.104,183.651,215.60532.30
AUROPHARMA17,371.3114,451.273,425.762,066.53
LUPIN14,088.5813,878.47427.52-849.21
All values are in crores

Biocon  
Similar Stocks

Cipla

Cipla

CIPLA

 ₹ 1,485.85
- ₹ 3.30
-0.22%
Dr. Reddy's Laboratories
 ₹ 5,875.60
- ₹ 22.10
-0.37%
Lupin

Lupin

LUPIN

 ₹ 1,626.70
- ₹ 5.95
-0.36%
Torrent Pharmaceuticals
 ₹ 2,656.55
- ₹ 36.35
-1.34%
Glaxosmithkline Pharmaceuticals
 ₹ 2,473.30
- ₹ 0.25
-0.01%

Biocon Share Price

Biocon Limited is an Indian biopharmaceutical company focused on the treatment of diabetes, cancer and autoimmune diseases. Its segment includes generics, similar biologics, novel biologics and research services. It has developed and commercialised novel biologics, biosimilars and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as generic formulations in the US, Europe and key emerging markets. Its API portfolio includes cardiology, diabetes, immunosuppressants, multiple sclerosis, cancer/oncology and other key products. Its products include tacrolimus, rosuvastatin, simvastatin, atorvastatin, pravastatin, fingolimod and others. It has more than five locations in Bangalore, Hyderabad and Visakhapatnam in India. Its API production facilities use sophisticated technology platforms ranging from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Biocon FAQs

How to Buy Biocon Share?

virtual
To purchase Biocon shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Biocon (ticker symbol: biocon) on the trading platform provided by your broker and purchase the shares.

What's Biocon share price today?

virtual
The stock price of Biocon as of 24 May 2024 is ₹324.50

What is the Market Cap of Biocon?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 24 May 2024, Biocon (ticker symbol: biocon) has a market capitalisation of approximately ₹3,02,67,12,60,000.00

What is the PE and PB ratio of Biocon?

virtual
Biocon Ltd's price-to-book ratio as of 24 May 2024 is 4.951752, reflecting the market's valuation compared to its asset value. As of 24 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 264.23935, indicating the market values the company at around ₹264.24 for every ₹1 of earnings

What is the 52 Week High and Low of Biocon Share?

virtual
Biocon Ltd (biocon) hit its 52-week high at ₹321.20, and its 52-week low at { ₹217.50}.
Want to learn and earn in Stocks?